T2 Biosystems Inc (TTOO)
0.79
-0.01
(-1.25%)
USD |
NASDAQ |
Nov 05, 16:00
0.79
0.00 (0.00%)
After-Hours: 16:02
T2 Biosystems Profit Margin (Quarterly): -459.2% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -459.2% |
| March 31, 2024 | -656.7% |
| December 31, 2023 | -615.8% |
| September 30, 2023 | -1.05K% |
| June 30, 2023 | -323.2% |
| March 31, 2023 | -864.5% |
| December 31, 2022 | -184.2% |
| September 30, 2022 | -472.5% |
| June 30, 2022 | -305.1% |
| March 31, 2022 | -228.0% |
| December 31, 2021 | -174.0% |
| September 30, 2021 | -188.0% |
| June 30, 2021 | -186.4% |
| March 31, 2021 | -153.2% |
| December 31, 2020 | -127.2% |
| September 30, 2020 | -214.6% |
| June 30, 2020 | -418.7% |
| March 31, 2020 | -587.4% |
| December 31, 2019 | -457.5% |
| September 30, 2019 | -845.0% |
| June 30, 2019 | -867.4% |
| March 31, 2019 | -848.6% |
| December 31, 2018 | -845.4% |
| Date | Value |
|---|---|
| September 30, 2018 | -436.6% |
| June 30, 2018 | -313.5% |
| March 31, 2018 | -558.8% |
| December 31, 2017 | -1.10K% |
| September 30, 2017 | -1.27K% |
| June 30, 2017 | -1.62K% |
| March 31, 2017 | -1.56K% |
| December 31, 2016 | -1.60K% |
| September 30, 2016 | -1.18K% |
| June 30, 2016 | -1.42K% |
| March 31, 2016 | -1.22K% |
| December 31, 2015 | -1.19K% |
| September 30, 2015 | -1.11K% |
| June 30, 2015 | -1.95K% |
| March 31, 2015 | -5.65K% |
| December 31, 2014 | -7.63K% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -11.59K% |
| September 30, 2013 | -5.10K% |
| June 30, 2013 | -4.18K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.05K%
Minimum
Sep 2023
-127.2%
Maximum
Dec 2020
-403.4%
Average
-323.2%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| Hologic Inc | 19.23% |
| Ekso Bionics Holdings Inc | -50.18% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 12.32% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -149.2% |
| Return on Invested Capital | -410.0% |
| Gross Profit Margin (Quarterly) | -37.96% |
| Operating Margin (Quarterly) | -490.5% |
| Return on Net Operating Assets | -307.8% |